8-K/A
filed May 5, 2026, 7:59 PM ET
ticker CHRN
CIK 0001549084
M&A
confidence high
sentiment neutral
materiality 0.95
EKSO BIONICS HOLDINGS, INC. (CHRN): auditor change — Ekso Bionics completes reverse merger with Applied Digital subsidiary; renames to ChronoScale Corp.
EKSO BIONICS HOLDINGS, INC.
- Applied Parent & Contributor now hold ~97% of outstanding shares; legacy Ekso holders retain ~3%.
- Company issued 138,216,820 new shares to Contributor for 100% of Cloud; post-merger shares outstanding 143,093,381.
- Applied Parent invested $15.75M via PIPE at $12.01/share, receiving 1,311,407 shares.
- Board reconstituted with 4 APLD designees (Wes Cummins as Chairman); ticker changes to 'CHRN' on Nasdaq.
- Fiscal year end changed to May 31; authorized common shares increased to 290M.
Key facts
Extracted from this filing and checked against the source text.
Auditor Changes
SEC 8-K Item 4.01/4.02
confidence 0.9
EKSO BIONICS HOLDINGS, INC. dismissed WithumSmith+Brown, PC as its auditor.
- Action
- dismissal
- Auditor
- WithumSmith+Brown, PC
- Successor
- CBIZ CPAs P.C.
Exact text from the filing
On May 5, 2026, the audit committee of the Board approved (i) the termination of the engagement of WithumSmith+Brown, PC
View on SEC.gov
Auditor Changes
SEC 8-K Item 4.01/4.02
confidence 0.9
EKSO BIONICS HOLDINGS, INC. engaged CBIZ CPAs P.C. as its auditor.
- Action
- engagement
- Auditor
- CBIZ CPAs P.C.
Exact text from the filing
ay 5, 2026, the audit committee of the Board approved (i) the termination of the engagement of WithumSmith+Brown, PC (“Withum”), the Company’s independent registered public accounting firm prior to the Business Combination, and (ii) the engagement of CBIZ
View on SEC.gov
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.9
EKSO BIONICS HOLDINGS, INC. issued common stock.
- Security
- common stock
Exact text from the filing
The A&R Articles increased the number of authorized shares of Common Stock from 141,428,571 shares to 290,000,000 shares, while maintaining the par value of $0.001 per share.
View on SEC.gov
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.9
EKSO BIONICS HOLDINGS, INC. issued 1,311,407 shares of Common Stock of common stock to Applied Parent for $12.01 per share.
- Security
- common stock
- Shares
- 1,311,407 shares of Common Stock
- Purchaser
- Applied Parent
- Consideration
- $12.01 per share
Exact text from the filing
Parent 1,311,407 shares of Common Stock (the “Private Placement Shares”). The Private Placement Shares were sold in the APLD Parent PIPE Investment at an offering price of $12.01 per share, the closing price of the Common Stock on April 30, 2026, the date immediately preceding the date of execution of the Securities Purchase Agreement, for gross proceeds
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Ying Cenly Chen was appointed as Director at EKSO BIONICS HOLDINGS, INC..
- Action
- appointed
- Role
- Director
Exact text from the filing
the Board was reconstituted as follows: Wes Cummins (Chairman), Ella Benson, Ying Cenly Chen, the Company's Chief Executive Officer, William M. Clancy, Scott G. Davis, Douglas Miller and Richard Nottenburg
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Douglas Miller was appointed as Director at EKSO BIONICS HOLDINGS, INC..
- Action
- appointed
- Role
- Director
Exact text from the filing
the Board was reconstituted as follows: Wes Cummins (Chairman), Ella Benson, Ying Cenly Chen, the Company's Chief Executive Officer, William M. Clancy, Scott G. Davis, Douglas Miller and Richard Nottenburg
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
William M. Clancy was appointed as Director at EKSO BIONICS HOLDINGS, INC..
- Action
- appointed
- Role
- Director
Exact text from the filing
the Board was reconstituted as follows: Wes Cummins (Chairman), Ella Benson, Ying Cenly Chen, the Company's Chief Executive Officer, William M. Clancy, Scott G. Davis, Douglas Miller and Richard Nottenburg
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Scott G. Davis was appointed as Director at EKSO BIONICS HOLDINGS, INC..
- Action
- appointed
- Role
- Director
Exact text from the filing
the Board was reconstituted as follows: Wes Cummins (Chairman), Ella Benson, Ying Cenly Chen, the Company's Chief Executive Officer, William M. Clancy, Scott G. Davis, Douglas Miller and Richard Nottenburg
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Richard Nottenburg was appointed as Director at EKSO BIONICS HOLDINGS, INC..
- Action
- appointed
- Role
- Director
Exact text from the filing
the Board was reconstituted as follows: Wes Cummins (Chairman), Ella Benson, Ying Cenly Chen, the Company's Chief Executive Officer, William M. Clancy, Scott G. Davis, Douglas Miller and Richard Nottenburg
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Mary Ann Cloyd resigned as Director at EKSO BIONICS HOLDINGS, INC..
- Action
- resigned
- Role
- Director
Exact text from the filing
the following directors tendered their resignations from the Board and each committee of the Board on which each such director respectively served: Mary Ann Cloyd, Corinna Lathan, Ph.D., Charles Li, Ph.D., and Deborah Lafer Scher
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Ella Benson was appointed as Director at EKSO BIONICS HOLDINGS, INC..
- Action
- appointed
- Role
- Director
Exact text from the filing
the Board was reconstituted as follows: Wes Cummins (Chairman), Ella Benson, Ying Cenly Chen, the Company's Chief Executive Officer, William M. Clancy, Scott G. Davis, Douglas Miller and Richard Nottenburg
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Charles Li resigned as Director at EKSO BIONICS HOLDINGS, INC..
- Action
- resigned
- Role
- Director
Exact text from the filing
the following directors tendered their resignations from the Board and each committee of the Board on which each such director respectively served: Mary Ann Cloyd, Corinna Lathan, Ph.D., Charles Li, Ph.D., and Deborah Lafer Scher
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Corinna Lathan resigned as Director at EKSO BIONICS HOLDINGS, INC..
- Action
- resigned
- Role
- Director
Exact text from the filing
the following directors tendered their resignations from the Board and each committee of the Board on which each such director respectively served: Mary Ann Cloyd, Corinna Lathan, Ph.D., Charles Li, Ph.D., and Deborah Lafer Scher
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Deborah Lafer Scher resigned as Director at EKSO BIONICS HOLDINGS, INC..
- Action
- resigned
- Role
- Director
Exact text from the filing
the following directors tendered their resignations from the Board and each committee of the Board on which each such director respectively served: Mary Ann Cloyd, Corinna Lathan, Ph.D., Charles Li, Ph.D., and Deborah Lafer Scher
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Wes Cummins was appointed as Chairman of the Board at EKSO BIONICS HOLDINGS, INC..
- Action
- appointed
- Role
- Chairman of the Board
Exact text from the filing
the Board was reconstituted as follows: Wes Cummins (Chairman), Ella Benson, Ying Cenly Chen, the Company's Chief Executive Officer, William M. Clancy, Scott G. Davis, Douglas Miller and Richard Nottenburg
View on SEC.gov
Governance Changes
SEC 8-K Item 5.03/5.05/5.06
confidence 0.9
EKSO BIONICS HOLDINGS, INC.: Second Amended and Restated Articles of Incorporation filed with Nevada Secretary of State, effective May 5, 2026, including name change to ChronoScale Corporation, increase in authorized common shares from 141,428,571 to 290,000,000, and other changes (effective 2026-05-05).
- Change
- charter amendment
- Effective
- 2026-05-05
Exact text from the filing
on May 1, 2026, the Company filed the Second Amended and Restated Articles of Incorporation (the “A&R Articles”) with the Secretary of State of the State of Nevada with a delayed effective date and time of 3:00 a.m. (Eastern Time) on May 5, 2026.
View on SEC.gov
Governance Changes
SEC 8-K Item 5.03/5.05/5.06
confidence 0.9
EKSO BIONICS HOLDINGS, INC.: Changed fiscal year end from December 31 to May 31.
- Change
- fiscal year change
Exact text from the filing
In connection with the Business Combination, as of the Closing Date, the Company changed its fiscal year end from December 31 to May 31.
View on SEC.gov
Governance Changes
SEC 8-K Item 5.03/5.05/5.06
confidence 0.9
EKSO BIONICS HOLDINGS, INC.: Second Amended and Restated Bylaws adopted effective upon Closing on May 5, 2026 (effective 2026-05-05).
- Change
- bylaw amendment
- Effective
- 2026-05-05
Exact text from the filing
Upon Closing and effective upon Closing, the Company adopted the Second Amended and Restated Bylaws (the “A&R Bylaws” and, together with the A&R Articles, the “Amended Charter Documents”).
View on SEC.gov
M&A Transactions
SEC 8-K Item 2.01/5.01
confidence 0.9
EKSO BIONICS HOLDINGS, INC. underwent a change of control involving Applied Digital Corporation (closed 2026-05-05).
- Action
- change of control
- Counterparty
- Applied Digital Corporation
- Closing
- 2026-05-05
Exact text from the filing
On May 5, 2026 (the “Closing Date”), Ekso Bionics Holdings, Inc., a Nevada corporation (“Ekso” or the “Company”), consummated the previously announced business combination transaction (the “Business Combination”) contemplated by that certain Contribution and Exchange Agreement
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.